DOXORUBICIN IN PREGNANCY - POSSIBLE TRANS-PLACENTAL PASSAGE

被引：0

作者：

KARP, GI

VONOEYEN, P

VALONE, F

KHETARPAL, VK

ISRAEL, M

MAYER, RJ

FRIGOLETTO, FD

GARNICK, MB

机构：

[1] HARVARD UNIV,SCH MED,BRIGHAM & WOMENS HOSP,DEPT OBSTET & GYNECOL,BOSTON,MA 02115

[2] HARVARD UNIV,SCH MED,BRIGHAM & WOMENS HOSP,DANA FARBER CANC INST,BOSTON,MA 02115

来源：

CANCER TREATMENT REPORTS | 1983年 / 67卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：773 / 777

页数：5

共 39 条

[1] BACHUR NR, 1975, CANCER CHEMOTH REP 3, V6, P153
[2] BACHUR NR, 1974, J PHARMACOL EXP THER, V191, P331
[3] BENJAMIN RS, 1975, CANCER CHEMOTH REP 3, V6, P183
[4] DIFFERENT INCIDENCE OF BREAST CARCINOMAS OR FIBROADENOMAS IN DAUNOMYCIN OR ADRIAMYCIN TREATED RATS
BERTAZZO.C
CHIELI, T
SOLCIA, E
[J]. EXPERIENTIA, 1971, 27 (10): : 1209 - &
[5] BLUM RH, 1975, CANCER CHEMOTH REP 3, V6, P247
[6] INTRAUTERINE GROWTH RETARDATION FOLLOWING 3RD-TRIMESTER EXPOSURE TO BUSULFAN
BOROS, SJ
REYNOLDS, JW
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1977, 129 (01) : 111 - 112
[7] CHOW WS, 1981, P AM ASS CANCER RES, V21, P1228
[8] COLBERT N, 1980, NOUV PRESSE MED, V9, P175
[9] DIAMOND I, 1960, PEDIATRICS, V25, P85
[10] DONEY KC, 1979, CANCER TREAT REP, V63, P369